Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present NuGene International, Inc. (OTC: NUGN).

Full DD Report for NUGN

You must become a subscriber to view this report.



Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-180.00340.003550.003550.00344,480
2018-12-17N/A0.0034N/AN/A0
2018-12-140.00370.00340.00370.0034600
2018-12-130.00340.00340.00340.0034507
2018-12-120.003430.003430.003430.003432,500

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-10-1935,68871,37650.0000Short
2018-10-0135,80058,43861.2615Short
2018-09-2622,43522,53599.5562Short
2018-09-2136,92437,02499.7299Short
2018-09-2016,77619,02688.1741Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on NUGN.


About NuGene International, Inc. (OTC: NUGN)

Logo for NuGene International, Inc. (OTC: NUGN)

NuGene International, Inc. develops and markets a diverse line of proprietary stem cell based regenerative cosmeceutical products, all resulting from well accepted, adult human stem cell derived conditioned media obtained through NuGene s patent pending adipose derived stem cell culture process. All of NuGene s products combine its in house advancements, proprietary, and patent pending technologies and formulations. Through its licensing relationship with kathy ireland Worldwide one of the most powerful global brands, according to License Global Magazine , NuGene markets a direct to consumer line branded under the kathy ireland brand, NuGene kathyireland. NuGene also markets a high end professional line of its products through professional channels such as dermatologists, plastic surgeons, medical offices, and day and resort spas, in addition to a regenerative hair product under the name Revellus. NuGene s research and formulation for biopharma products for wound healing and burn treatment is ongoing with a view to commercialization. With multiple patents pending and proprietary formulas, processes, and applications, NuGene s goal is to become the industry leader for age defying skincare and hair care products, in addition to pharmaceutical products based on the same regenerative stem cell technology platform. For more information on NuGene and its stem cell based product lines, visit www.NuGene.com.

 

Contact Information

 

 

Current Management

  • Mohammad Ali Kharazmi / CEO
  • Keith Rosenbaum / Legal Counsel
  • Mohammad Saeed Kharazmi /

Current Share Structure

  • Market Cap: $299,371 - 03/09/2018
  • Authorized: 100,000,000 - 03/01/2018
  • Issue and Outstanding: 42,767,355 - 03/01/2018
  • Float: 22,415,550 - 11/02/2017

 



Daily Technical Chart for (OTC: NUGN)

Daily Technical Chart for (OTC: NUGN)


Stay tuned for daily updates and more on (OTC: NUGN)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: NUGN)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in NUGN is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of NUGN and does not buy, sell, or trade any shares of NUGN. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/